Schelling Chris

President & CEO, Director, 10% OwnerAcer Therapeutics Inc. (ACER) · full profile →Form 4 · filed Dec 1, 2022
Net Buying
Open-Market Buys
$1.0M
Open-Market Sells
$0
Net Open-Market Flow
$1.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 29, 2022Buy(P)820K$1.22$1000K2.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-059174) within minutes of acceptance. Every field above traces to the original document. Verify it directly: